Analysis of European Biosimilars Market

Huge Market Opportunity from Impending Patent Expiries of Blockbuster Biologics.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments.

Table of Contents

Analysis of European Biosimilars Market, Executive SummarySummary of European Biosimilars MarketExecutive SummaryAnalysis of European Biosimilars Market, Total Biosimilars MarketIntroduction to the Total Biosimilars MarketTotal Biosimilars Market OverviewForecast and Trends - Global Biosimilars MarketMarket Share and Competitive Analysis - Global Biosimilars MarketAnalysis of European Biosimilars Market, European Biosimilars MarketIntroduction to European Biosimilars MarketEuropean Biosimilars Market OverviewChallenges; Drivers and Restraints - European Biosimilars MarketForecast and Trends - European Biosimilars MarketDemand Analysis - European Biosimilars MarketMarket Share and Competitive Analysis - European Biosimilars MarketRegulatory Guidelines - European Biosimilars MarketEuropean Erythropoietin Biosimilars MarketEuropean Erythropoietin Biosimilars Market OverviewForecast and Trends - European Erythropoietin Biosimilars MarketMarket Share and Competitive Analysis - European Erythropoietin Biosimilars MarketRegulatory Guidelines - European Erythropoietin Biosimilars MarketEuropean Granulocyte Colony Stimulating Factors Biosimilars MarketEuropean Granulocyte Colony Stimulating Factors Biosimilars Market OverviewForecast and Trends - European Granulocyte Colony Stimulating Factors Biosimilars MarketMarket Share and Competitive Analysis - European Granulocyte Colony Stimulating Factors Biosimilars MarketRegulatory Guidelines - European Granulocyte Colony Stimulating Factors Biosimilars MarketEuropean Human Growth Hormone Biosimilars MarketEuropean Human Growth Hormone Biosimilars Market OverviewForecast and Trends - European Human Growth Hormone Biosimilars MarketMarket Share and Competitive Analysis - European Human Growth Hormone Biosimilars MarketRegulatory Guidelines - European Human Growth Hormone Biosimilars MarketEuropean Monoclonal Antibodies Biosimilars MarketEuropean Monoclonal Antibodies Biosimilars Market OverviewMarket Analysis - European Monoclonal Antibodies Biosimilars MarketRegulatory Guidelines - European Monoclonal Antibodies Biosimilars MarketEuropean Insulin Biosimilars MarketEuropean Insulin Biosimilars Market OverviewMarket Analysis - European Insulin Biosimilars MarketRegulatory Guidelines - European Insulin Biosimilars MarketEuropean Interferon Biosimilars MarketEuropean Interferon Biosimilars Market OverviewMarket Analysis - European Interferon Biosimilars MarketRegulatory Guidelines - European Interferon Biosimilars MarketAnalysis of European Biosimilars Market, Regional Analysis of European Biosimilars MarketBiosimilars Market - The United KingdomThe United Kingdom Biosimilars Market OverviewForecast and Trends - The United Kingdom Biosimilars MarketBiosimilars Market - GermanyGermany Biosimilars Market OverviewForecast and Trends - Germany Biosimilars MarketBiosimilars Market - FranceFrance Biosimilars Market OverviewForecast and Trends - France Biosimilars MarketBiosimilars Market - ItalyItaly Biosimilars Market OverviewForecast and Trends - Italy Biosimilars MarketBiosimilars Market - SpainSpain Biosimilars Market OverviewForecast and Trends - Spain Biosimilars MarketBiosimilars Market - BeneluxBenelux Biosimilars Market OverviewForecast and Trends - Benelux Biosimilars MarketBiosimilars Market - ScandinaviaScandinavia Biosimilars Market OverviewForecast and Trends - Scandinavia Biosimilars MarketAnalysis of European Biosimilars Market, Product ProfilingProducts in the Biosimilars MarketProduct Profiling - Biosimilars in EuropeProduct Profiling - BiologicsFuture Landscape AnalysisAnalysis of European Biosimilars Market, Conclusions and Strategic RecommendationsConclusions of the study and Strategic Recommendations for Market ParticipantsConclusions and Strategic RecommendationsThe Last WordAnalysis of European Biosimilars Market, AppendixData TablesDecision Support DatabasesAbbreviationsMarket Engineering Methodology




Related Research

Release Date : 18-Sep-17

Region : Europe

Release Date : 15-Sep-17

Region : Europe

Release Date : 08-Sep-17

Region : Europe

Release Date : 06-Sep-17

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.